No contribution of ascorbic acid to renal calcium oxalate stones

Annals of Nutrition and Metabolism

Volumn 41, Issue 5, 1997, Pages 269-282

  Gerster, Helga ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Ascorbic acid; Calcium oxalate; Kidney calculi; Urinary oxalate

Indexed keywords

ASCORBIC ACID; CALCIUM OXALATE;

ASSAY; CALCIUM OXALATE STONE; DIET SUPPLEMENTATION; FOLLOW UP; GASTROINTESTINAL ABSORPTION; HUMAN; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; MEDICAL LITERATURE; NEPHROLITHIASIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; RISK; URINE; VITAMIN INTAKE; VITAMIN METABOLISM;

EID: 0030829917     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000177954     Document Type: Article

References (66)

1. IJC in man. J Biol Chem 1958;230:923-930.
2. Smith LH: Risk of oxalate stones from large doses of vitamin C. N Engl J Med 1978:298:856.
3. Roth DA: Vitamin C and oxalate stones. JAMA 1977:237:768.
4. Hornig D: Metabolism of ascorbic acid. World Rev Nutr Diet 1975:3: 225-258.
5. Gerster H: Do high doses of vitamin C cause kidney stones? Ernähr Nutr 1986:10:614-617.
6. Toggenburgcr G, Häusermann M, Mütsch B, Genoni G, Kessler M, Weber F, Hornig D, O’Neill B, Se-menza G: Na*-dependent. potential-sensitive ¿-ascorbate transport across brush border membrane vesicles from kidney cortex. Biochim Biophys Acta 1981;646:433-443.
7. Hornig D. Vuillcumier JP. Hartmann D: Absorption of large, single, oral intakes of ascorbic acid. Int J Vitam Nutr Res 1980;50:309-314.
8. Kallner A, Hartmann D. Hornig D: Steady-state turnover and body pool of ascorbic acid in man. Am J Clin Nutr 1979;32:530-539.
9. Kiiblcr W, Gehler J: Zur Kinetik der enteralen Ascorbinsäure-Resorption: Ein Beitrag zur Berechnung nicht dosisproportionaler Resorptionsvorgänge. Int Z Vitaminforsch 1970:40:442-452.
10. Hughes C, Dutton S, Truswell AS: High intakes of ascorbic acid and urinary oxalate. J Hum Nutr 1981; 35:274-280.
11. Melcthil S, Mason WD, Chang ChJ: Dose-dependent absorption and excretion of vitamin C in humans. Int J Pharm 1986:31:83-89.
12. King G. Beins M, Larkin J, Summers B, Ordman AB: Rate of excretion of vitamin C in human urine. Age 1994;17:87-92.
13. 4C acid in experimental human scurvy. Am J Clin Nutr 1969;22:549-558.
14. Kallner A, Hornig D, Pellikka R: Fonnation of carbon dioxide from ascorbate in man. Am J Clin Nutr 1985;41:609-613.
15. Williams HE. Wandzilak TR: Oxalate synthesis, transport and the hy-pcroxaluric syndromes. J Urol 1989; 141:742-747.
16. Berg W, Herling R. Bothor C, Mei-nig S, Escholz A, Schulze HP: Diagnostik der enteralen Oxalathyperabsorption bei Patienten mit idiopathischem rezidivierendem Kalzi-umoxalathamsteinleiden. Urologe A 1990:29:148-151.
17. Lindsjö M. Danielson BG, Fcil-ström B, Ljunghall S: Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects. Scand J Urol Nephrol 1989;23:55-59.
18. Heckers H, Wagner I, Schmelz E, Trcnkcl A: Zur diätetischen Therapie und Prävention von Calcium-oxalat-Niercnsteinen. Emährungs-umschau 1993:40:416-420.
19. Chalmers AH, Cowley DM, McWhinney BC: Stability of ascorbate in urine: Relevance to analyses for ascorbate and oxalate. Clin Chem 1985:31:1703-1705.
20. Fituri N, Allawi M, Costello BJ: Urinary and plasma oxalate during ingestion of pure ascorbic acid: A re-evaluation. Eur Urol 1983:9:312-315.
21. Hatch M. Mulgrew S. Bourke E. Keogh B. Costello J: Effect of megadoses of ascorbic acid on serum and urinary oxalate. Eur Urol 1980;6:166-169.
22. Schmidt KII. Hagmaicr V, Hornig DH, Vuilleumier JP. Rutishauser G: Urinarv oxalate excretion after large intakes of ascorbic acid in man. Am J Clin Nutr 1981:34:305-311.
23. Schmidt K, Hagmaicr V, Bruchelt G, Rutishauser G: Analytical iso-tachophoresis: A rapid and sensitive method for determination of urinary oxalate. Urol Res 1980:8:177-180.
24. Liedkc RR. Wilson DM. Mover TP. Wandzilak T. Williams H: Analysis of immobilized oxalate-oxidase method in urine: Problems solved and methods compared; in Walker VR, Sutton RAL. Cameron ECB. Pak CYC, Robertson WG (eds): Urolithiasis. New York. Plenum Press. 1989. pp 535-538.
25. Tiselius HG, Almgard LE: The diurnal urinary excretion of oxalate and the effect of pyridoxine and ascorbate on oxalate excretion. Eur Urol 1977;3:41-46.
26. Chalmers AH. Cowley DM. Brown JM: A possible etiological role for ascorbate in calculi formation. Clin Chem 1986:32:333-336.
27. Urivetzky M. Kessaris D. Smith AD: Ascorbic acid overdosing: A risk factor for calcium oxalate nephrolithiasis. J Urol 1992:147:1215-1218.
28. Costello J: Ascorbic acid overdosing: A risk factor for calcium oxalate nephrolithiasis. J Urol 1993; 149: 1146.
29. Chalmers A: Ascorbic acid overdosing: A risk factor for calcium oxalate nephrolithiasis. J Urol 1994:152: 171.
30. Wandzilak TR. D'Andre SD. Davis PA. Williams HE: Effect of high dose vitamin C on urinary oxalate levels. J Urol 1994; 151:834-837.
31. Levine M, Conry-Cantilcna C, Wang Y. Welch RW, Washko PW, Dhariwal KR. Park JB. Lazarev A. Graumlich JF, King J. Cantilena LR: Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc Natl Acad Sei USA 1996:93: 3704-3709.
32. Li MG. Madappally MM: Rapid enzymatic determination of urinary oxalate. Clin Chem 1989:35:2330-2333.
33. Levine M. Dhariwal KR. Welch RW. Wang AY. Park JB: Determination of optimal vitamin C requirements in humans. Am J Clin Nutr 1995:62(suppl): 1347-1356.
34. McMichael AJ: Kidney stone hospitalisations in relation to changes in vitamin C consumption in Australia, 1966-76. Community Health Stud 1978;11:13-17.
35. Curhan GC. Curhan SG: Dietary factors and kidney stone formation. ComprThcr 1994;20:485-489.
36. Hiatt RA. Ettinger B. Caan B. Que-senberry CP. Duncan D. Citron JT: Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol 1996:144:25-33.
37. Hemilä H: Vitamin C and the common cold. Br J Nutr 1992:67:3-16.
38. Davie SJ, Gould BJ, Yudkin JS: Effect of vitamin C on glycosylation of proteins. Diabetes 1992:41:167-173.
39. Eriksson J. Kohvakka A: Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 1995;39:217-223.
40. I Bucca C. Rolla C. Farina JC: Effect of vitamin C on transient increase of bronchial responsiveness in conditions affecting the airways. Ann NY Acad Sei 1992;669:175-187.
41. Simon JA: Vitamin C and cardiovascular disease: A review. J Am Coll Nutr 1992;11:107-125.
42. Greenberg ER. Baron JA. Tosteson TD. Freeman DH. Beck GJ. Bond JH. Colacchio TA. Coller J A. Frank] HD. Haile RW. Mandel JS. Nieren-berg DW. Rothstein R. Snover DC. Stevens MM. Summers RW. van Slolk RU: A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994:331: 141-147.
43. Curhan GC, Willett WC, Rimm EB. Slampfer MJ: A prospective study of the intake of vitamins C and IT, and the risk of kidney stones in men. J Urol 1996:155:1847-1851.
44. Curhan GC. Willett WC. Rimm EB. Stampfer MJ: A prospective study of dietary calcium and other nutrients and their risk of symptomatic kidney stones. N Engl J Med 1993,328: 833-838.
45. Goldfarb S: Dietary factors in the pathogenesis and prophylaxis of calcium nephrolithiasis. Kidney Ini 1988:34:544-555.
46. Wasserstein AG, Stolley PD, Soper KA, Goldfarb S, Maislin G, Agus Z: Case-control study of risk factors for idiopathic calcium nephrolithiasis. Miner Electrolyte Metab 1987:13: 85-95.
47. Fellstrôm B, Danielson BG, Karl-strôm B, Lithell H, Junghal! SL, Vessby B: Dietary habits in renal stone patients compared with healthy subjects. Br J Urol 1989;63: 575-580.
48. Power C, Barker DJP, Nelson M, Winter PD: Diet and renal stones: A case-control study. Br J Urol 1984; 56:456-459.
49. Khanam A, Rahman B, Rahman MA: Role of vitamins in urolithiasis. Biomed Pharmacother 1988:42: 609-614.
50. Trinchieri A, Mandressi A, Luongo P. Longo G. Pisani E: The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers. BrJ Urol 1991:67:230-236.
51. Borsatti A: Calcium oxalate nephrolithiasis. Kidney Int 1991:39: 1283-1298.
52. Jackson P. Lougrcy CM. Lightbody JH. McNamce PT. Young IS: Effect of hemodialysis on total antioxidant capacity and scrum antioxidants in patients with chronic renal failure. Clin Chem 1995;41:1135-1138.
53. Balcke P, Schmidt P, Zazgomik J, Kopsa H, Haubcnstock A: Ascorbic acid aggravates secondary hyperox-alemia in patients on chronic hemodialysis. Ann Intern Med 1984:101: 344-345.
54. Swartz RD, Wesley JR, Somcr-meyer MG, Lau K: Hyperoxaluria and renal insufTtciency due to ascorbic acid administration during total parenteral nutrition. Ann Intern Med 1984:100:530.
55. McAllister CJ, Scowden EB, Dewberry FL, Richman A: Renal failure secondary to massive infusion of vitamin C. JAMA 1984:252:1684.
56. Ross EA, Shah GM, Costello H, Bhagavan H, Sabo A, Pichon M: Oxalate metabolism in peritoneal dialysis patients receiving vitamin C supplements. Kidney Int 1989:35: 275.
57. Ono K: The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients. Clin Nephrol 1989:31:31-34.
58. Wong K. Thomson C. Bailey RR. McDiarmid S. Gardner J: Acute oxalate nephropathy after massive intravenous dose of vitamin C. Aust NZJ Med 1994:24:410-411.
59. Morgan SH. Maher ER. Purkiss P. Watts RWE. Curtis JR: Oxalate metabolism in end-stage renal disease: The effect of ascorbic acid and pyri-doxine. Nephrol Dial Transplant 1988:3:28-32.
60. Tomson CRV, Channon SM, Parkinson IS, McArdle P, Qureshi M, Ward MK, Laker MF: Correction of subclinical ascorbate deficiency in patients receiving dialysis: Effects on plasma oxalate, serum cholesterol and capillary fragility. Clin Chim Acta 1989;180:255-264.
61. Shah GM, Ross EA, Sabo A, Pichon M. Reynolds RD. Bhagavan H: Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients. Am J Kidney Dis 1992;20:42-49.
62. Rolton HA, McConnell KM, Modi KS, Macdougall Al: The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis. Nephrol Dial Transplant 1991; 6:440-443.
63. Smith LH: The medical aspects of urolithiasis: An overview. J Urol 1989;141:707-710.
64. Cordonnier C, Noel C, Gosselin B: Les oxaloses. Ann Pathol 1995:15: 415-423.
65. Coe FL, Nakagawa Y, Asplin J, Parks JH: Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Miner Electrolyte Metab 1994:20:378-384.
66. Hess B: The role of Tamm-Horsfall glycoprotein and nephrocalcin in calcium oxalate monohydrate crystallization processes. Scanning Mi-crosc 1991;5:689-696.